First patient enrolled in Oxford BioDynamics’ ALS biomarker study
First patient enrolled in Oxford BioDynamics’ ALS biomarker study - PharmaTimes
Oxford BioDynamics welcomes commencement of new US clinical trial
Oxford BioDynamics welcomes commencement of new US clinical trial, 25 Oct 2�19 �7:22 | Shares Magazine
Haven't heard of new trial start in a while; today we have two.